Skip to content

Effect of dexmedetomidine on central nervous system complications in patients undergoing cardiac surgery

Effect of intraoperative dextrometomidine on complications of the central nervous system in patients undergoing cardiac surgery: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081864
Enrollment
Unknown
Registered
2024-03-14
Start date
2024-04-03
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative complications of the central nervous system

Interventions

Intervention group:Intravenous infusion of 0.6µg/kg load dose of dexmedetomidine within 10 minutes after intubation, followed by continuous infusion at a rate of 0.4 µg/kg/h until 30 minutes before th
Control group:Provide equal volume of physiological saline

Sponsors

The First Medical Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age range from 18 to 85 years old, regardless of gender 2. Patients who undergo cardiac surgery on a scheduled basis; 3. ASA level 1-4; 4. Obtain written informed consent form;

Exclusion criteria

Exclusion criteria: 1. Patients with MMSE scores less than 18 or dementia, intellectual disability, and inability to communicate (coma, severe dementia, hearing or language impairment); 2. Have a history of mental or neurological disorders (such as schizophrenia, epilepsy, Parkinson's disease, or severe myasthenia gravis); 3. Previous history of brain injury; 4. Severe liver dysfunction (Child pugh C-grade) or renal insufficiency (preoperative dialysis); 5. Severe bradycardia (heart rate below 50 beats per minute), pathological sinus syndrome, or atrioventricular block without a pacemaker; 6. Postoperative intensive care unit (ICU) duration exceeding 7 days or death;

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative depression;The incidence of postoperative anxiety;

Secondary

MeasureTime frame
The incidence of postoperative delirium;Postoperative Pain;Postoperative sleep disorders;Postoperative quality of life evaluation;Postoperative mortality rate;Surgical related complications;

Countries

China

Contacts

Public ContactMi Weidong

The First Medical Center, Chinese PLA General Hospital

haoxinyu19980206@163.com+86 133 8108 2966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026